Drug Profile
Hirudin injection - Simcere
Alternative Names: rh-RGD-HirudinLatest Information Update: 24 Jul 2015
Price :
$50
*
At a glance
- Originator Simcere Pharmaceutical Group
- Class Antithrombins; Hirudins
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 06 Jul 2011 Phase-II clinical trials in Thrombosis in China (Parenteral)